[go: up one dir, main page]

FR3068039B1 - Composition auto-moussante en milieu acide et procede de preparation - Google Patents

Composition auto-moussante en milieu acide et procede de preparation Download PDF

Info

Publication number
FR3068039B1
FR3068039B1 FR1755695A FR1755695A FR3068039B1 FR 3068039 B1 FR3068039 B1 FR 3068039B1 FR 1755695 A FR1755695 A FR 1755695A FR 1755695 A FR1755695 A FR 1755695A FR 3068039 B1 FR3068039 B1 FR 3068039B1
Authority
FR
France
Prior art keywords
self
acid medium
preparation
foaming composition
hydrophilic polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1755695A
Other languages
English (en)
Other versions
FR3068039A1 (fr
Inventor
Jean-Michel Simon
Stephane Roger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jellynov
Original Assignee
Jellynov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1755695A priority Critical patent/FR3068039B1/fr
Application filed by Jellynov filed Critical Jellynov
Priority to EP18737956.5A priority patent/EP3642274A1/fr
Priority to MX2019015270A priority patent/MX2019015270A/es
Priority to PCT/FR2018/051462 priority patent/WO2018234680A1/fr
Priority to BR112019027561-4A priority patent/BR112019027561B1/pt
Priority to IL271316A priority patent/IL271316B2/en
Priority to MA049480A priority patent/MA49480A/fr
Priority to US16/625,257 priority patent/US11471407B2/en
Priority to CA3067189A priority patent/CA3067189A1/fr
Publication of FR3068039A1 publication Critical patent/FR3068039A1/fr
Application granted granted Critical
Publication of FR3068039B1 publication Critical patent/FR3068039B1/fr
Priority to US17/897,690 priority patent/US12178906B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/04—Alginic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
    • C08J9/06—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a chemical blowing agent
    • C08J9/08—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a chemical blowing agent developing carbon dioxide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2203/00—Foams characterized by the expanding agent
    • C08J2203/02—CO2-releasing, e.g. NaHCO3 and citric acid
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2205/00—Foams characterised by their properties
    • C08J2205/02—Foams characterised by their properties the finished foam itself being a gel or a gel being temporarily formed when processing the foamable composition
    • C08J2205/022—Hydrogel, i.e. a gel containing an aqueous composition
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2205/00—Foams characterised by their properties
    • C08J2205/02—Foams characterised by their properties the finished foam itself being a gel or a gel being temporarily formed when processing the foamable composition
    • C08J2205/026—Aerogel, i.e. a supercritically dried gel
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2205/00—Foams characterised by their properties
    • C08J2205/02—Foams characterised by their properties the finished foam itself being a gel or a gel being temporarily formed when processing the foamable composition
    • C08J2205/028—Xerogel, i.e. an air dried gel
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2207/00—Foams characterised by their intended use
    • C08J2207/10—Medical applications, e.g. biocompatible scaffolds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/04—Alginic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/24—Acids; Salts thereof
    • C08K3/26—Carbonates; Bicarbonates
    • C08K2003/262—Alkali metal carbonates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/24—Acids; Salts thereof
    • C08K3/26—Carbonates; Bicarbonates
    • C08K2003/265—Calcium, strontium or barium carbonate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Animal Husbandry (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Une composition auto-moussante en milieu acide comprenant : - au moins un polymère hydrophile, - au moins un composé capable de réticuler le polymère hydrophile par la formation de liaisons ioniques, - au moins un agent moussant, et - au moins un agent stabilisant des mousses, et son utilisation comme médicament, notamment pour la prévention et/ou le traitement de l'obésité.
FR1755695A 2017-06-22 2017-06-22 Composition auto-moussante en milieu acide et procede de preparation Active FR3068039B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR1755695A FR3068039B1 (fr) 2017-06-22 2017-06-22 Composition auto-moussante en milieu acide et procede de preparation
CA3067189A CA3067189A1 (fr) 2017-06-22 2018-06-19 Composition auto-moussante en milieu acide et procede de preparation
PCT/FR2018/051462 WO2018234680A1 (fr) 2017-06-22 2018-06-19 Composition auto-moussante en milieu acide et procédé de préparation
BR112019027561-4A BR112019027561B1 (pt) 2017-06-22 2018-06-19 Composição que é auto-espumante em um meio ácido e método para preparar a mesma
IL271316A IL271316B2 (en) 2017-06-22 2018-06-19 Composition that is self-foaming in an acid medium, and method for preparing same
MA049480A MA49480A (fr) 2017-06-22 2018-06-19 Composition auto-moussante en milieu acide et procédé de préparation
EP18737956.5A EP3642274A1 (fr) 2017-06-22 2018-06-19 Composition auto-moussante en milieu acide et procédé de préparation
MX2019015270A MX2019015270A (es) 2017-06-22 2018-06-19 Composicion autoespumante en medio acido y procedimiento de preparacion.
US16/625,257 US11471407B2 (en) 2017-06-22 2018-06-19 Composition that is self-foaming in an acid medium, and method for preparing same
US17/897,690 US12178906B2 (en) 2017-06-22 2022-08-29 Method of administering a self-foaming composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1755695A FR3068039B1 (fr) 2017-06-22 2017-06-22 Composition auto-moussante en milieu acide et procede de preparation
FR1755695 2017-06-22

Publications (2)

Publication Number Publication Date
FR3068039A1 FR3068039A1 (fr) 2018-12-28
FR3068039B1 true FR3068039B1 (fr) 2020-07-10

Family

ID=59579757

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1755695A Active FR3068039B1 (fr) 2017-06-22 2017-06-22 Composition auto-moussante en milieu acide et procede de preparation

Country Status (8)

Country Link
US (2) US11471407B2 (fr)
EP (1) EP3642274A1 (fr)
CA (1) CA3067189A1 (fr)
FR (1) FR3068039B1 (fr)
IL (1) IL271316B2 (fr)
MA (1) MA49480A (fr)
MX (1) MX2019015270A (fr)
WO (1) WO2018234680A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020310211A1 (en) * 2019-07-11 2022-02-24 StenCo, LLC Biodegradable material
CN114409928B (zh) * 2022-02-07 2024-04-09 南京易亨制药有限公司 一种高弹性模量的聚合物水凝胶及其制备方法和其应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9305552A (pt) * 1992-06-19 1994-12-20 Albany Int Corp Processo para produzir espumas de polissacarídeos
US5840777A (en) * 1992-06-19 1998-11-24 Albany International Corp. Method of producing polysaccharide foams
CA2175225C (fr) * 1993-10-29 2004-09-21 Keith Graeme Hutchison Substance a pouvoir moussant garnissant une gelule de gelatine
US5750585A (en) 1995-04-04 1998-05-12 Purdue Research Foundation Super absorbent hydrogel foams
US6271278B1 (en) 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
US6018033A (en) 1997-05-13 2000-01-25 Purdue Research Foundation Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same
US6677318B1 (en) 2000-09-05 2004-01-13 Beisel Guenther Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said
US6696077B2 (en) * 2001-07-26 2004-02-24 George H. Scherr Silver alginate foam compositions
US20040192582A1 (en) 2002-12-19 2004-09-30 Burnett Daniel R. Ingestible formulations for transient, noninvasive reduction of gastric volume
EP1663326B1 (fr) * 2003-09-08 2010-03-03 FMC Biopolymer AS Mousse gelifiee a base de biopolymere
GB0324525D0 (en) * 2003-10-21 2003-11-26 British American Tobacco Co Smoking articles and smokable filler material therefor
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
FR2897529B1 (fr) 2006-02-17 2008-10-31 Cie Euro Etude Rech Paroscopie Ballon intra-gastrique a memoire de forme
BRPI0708429A2 (pt) * 2006-03-01 2011-05-31 Fmc Biopolymer As método para formar uma espuma absorvente seca, espuma absorvente seca, compósito, uso de uma espuma ou de um compósito, e, métodos para inibir a proliferação celular, para fixar um compósito ao tecido e para evitar a adesão de tecido a tecido adjacente
WO2007123598A1 (fr) * 2006-04-19 2007-11-01 Fmc Biopolymer As Mousse et son utilisation
EP2073792A2 (fr) * 2006-07-06 2009-07-01 Abbott Laboratories Hydrogels superporeux
WO2008157318A2 (fr) * 2007-06-13 2008-12-24 Fmc Corporation Composite de mousse de polysaccharide contenant du gel, revêtu d'alginate, procédés préparatoires, et son utilisation
MX2010001629A (es) 2007-08-10 2010-08-09 Alessandro Sannino Hidrogeles de polimero y metodos de preparacion de los mismos.
US8287562B2 (en) 2007-12-20 2012-10-16 7L, Llc Swallowable self-expanding gastric space occupying device
WO2010045477A2 (fr) 2008-10-16 2010-04-22 Obalon Therapeutics, Inc. Dispositif occupant un volume intra-gastrique et son procédé de fabrication
US20100100115A1 (en) 2008-10-20 2010-04-22 Wilson-Cook Medical Inc. Foam filled intragastric balloon for treating obesity
US20140106032A1 (en) * 2011-06-07 2014-04-17 Firmenich Sa Core-shell capsules
US8993539B2 (en) 2012-09-23 2015-03-31 Guang Yan Dietary fiber supplements for appetite suppression
CN105582029B (zh) 2014-10-21 2019-12-24 上海中医药大学 鸦胆子油漂浮型胃滞留微球及其制备方法
CN106750573B (zh) * 2016-11-22 2019-03-29 东南大学成贤学院 一种壳聚糖-海藻酸盐多孔凝胶及其制备和应用方法

Also Published As

Publication number Publication date
EP3642274A1 (fr) 2020-04-29
FR3068039A1 (fr) 2018-12-28
CA3067189A1 (fr) 2018-12-27
US12178906B2 (en) 2024-12-31
IL271316A (en) 2020-01-30
IL271316B1 (en) 2023-08-01
US20220409529A1 (en) 2022-12-29
US20200146980A1 (en) 2020-05-14
IL271316B2 (en) 2023-12-01
WO2018234680A1 (fr) 2018-12-27
US11471407B2 (en) 2022-10-18
BR112019027561A2 (pt) 2020-07-07
MA49480A (fr) 2020-04-29
MX2019015270A (es) 2020-08-17

Similar Documents

Publication Publication Date Title
PH12018501221A1 (en) Mixture of hmos
AU2016278853A8 (en) Petrolatum-based compositions comprising cationic biocides
MX2017001486A (es) Uso en composiciones detergentes de polimeros obtenidos por polimerizacion en emulsion inversa, a concentracion baja, con un bajo contenido de monomeros neutralizados.
PH12019501199A1 (en) Calcium lactate compositions and methods of use
DK2183309T3 (da) EO/PO-blokcopolymerer som stabilisatorer for PUR-skumstoffer
MX2017014526A (es) Aparato y metodo para invertir latices polimericos.
BR112017005650A2 (pt) método para tratar uma formação subterrânea, sistema para realizar o método para tratar uma formação subterrânea, composição para o tratamento de uma formação subterrânea e método para preparar uma composição para o tratamento de uma formação subterrânea
WO2018042438A3 (fr) Produits dérivés du sang humain à activité fibrinolytique réduite et leurs utilisations dans des troubles hémostatiques
FR3068039B1 (fr) Composition auto-moussante en milieu acide et procede de preparation
WO2019157495A3 (fr) Procédés de prévention et/ou de traitement de conditions de perte osseuse par modulation de l'irisine
EP4279128A3 (fr) Nouvel anticorps se liant à la tfpi et composition le comprenant
EA201800340A1 (ru) Кабель, содержащий вспененный слой, включающий полимер полиолефина и пенообразователь
FR3044663B1 (fr) Copolymere monofonctionnel ou telechelique de 1,3-butadiene et d'ethylene.
EP4279095A3 (fr) Pansement ayant une caractéristique d'épithélialisation et de réduction de cicatrice
MX2020011040A (es) Composicion para reparar tejido y metodo de fabricacion de la misma.
PH12017550005A1 (en) Drug-device unit containing quinagolide
BR112018072664A2 (pt) composições e métodos para tratamento de inflamação e infecção do olho
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
MX2019010536A (es) Tratamiento de agua producida con inundacion de polimero.
MX2019005483A (es) Estructura funcional tridimensional.
MX2019000006A (es) Composiciones para el tratamiento de estrias y ulceras de origen isquemico.
MX2022010018A (es) Dispositivo medico y procedimiento para generar un liquido activado por plasma.
MY177937A (en) Determination of the degree of branching
MX2019012970A (es) Nicotinamida para tratar dislipidemia.
WO2018094317A3 (fr) Liquides ioniques chélateurs d'argent et de cuivre, polymères et gels, et leurs utilisations

Legal Events

Date Code Title Description
PLSC Publication of the preliminary search report

Effective date: 20181228

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8